About Us

Team
Careers
Get to Know Us
History

About Us

Team
Careers
Get to Know Us
History

The Team

The core of ZuriMED is built by its people. Our interdisciplinary and diverse team is backed by a strong board of directors comprised of world-renowned experts. Together, we aim to push the boundaries of current orthopedic and sports medicine solutions through our innovative technologies.

Xiang Li

CEO & Co-Founder
Xiang holds a degree of Dr. sc. ETH Zurich in Orthopaedic Biomechanics, with over 15 years of experience in medical engineering. Along with business development, he has developed a comprehensive knowledge base in finance, legal, quality, and management. With a robust entrepreneurial sense and a firm vision, he leads operations to grow the company, and fosters an incentivising work environment that encourages innovation and motivates the team to create value for the company.

Elias Bachmann

CTO & Co-Founder
After completing his biomedical engineering studies, Elias spent several years as a research fellow at the Laboratory of Orthopaedic Biomechanics, Balgrist University Hospital, and ETH Zurich. His journey led him to co-found ZuriMED Technologies AG, where he is now responsible for the technical direction, strategy and development.

Pol Banzet

Head of Development
With a background in Mechanical Engineering with an orientation in Biomechanics, Pol spent time in academia (Master's Thesis in Harvard's Biodesign Lab and research assistant at ETH's Computational Robotics Laboratory), before joining ZuriMED in 2020. He now supervises the development of multiple medical devices, from early research prototypes to industrialization and early lifecycle management.

Sascha Brun

Head of Active Devices Development
Sascha holds an MSc in Mechanical Engineering, specializing in Robotics and Mechatronics, from ETH Zurich. He leads the development of powered devices at ZuriMED. After a traineeship at the Helbling Robotics Team and a research assistant position at the biomechanics lab, Sascha joined ZuriMED from the early days on.

Andrea Möhl

Head of Clinical Affairs
Andrea, Head of Clinical Affairs, holds an MSc in Health Science and Technology from ETH Zurich. She leads pre-clinical and clinical studies, playing a pivotal role in clinical evaluation processes. After a traineeship at DePuy Synthes and a research internship in the rehabilitation engineering field, Andrea joined ZuriMED for her master’s thesis and supported the Surgical-Fiberlock technology project from its early stages.

Sebastian Arevalo

Head of Quality
Sebastian leads ZuriMED's quality and regulatory compliance department. Backed by more than six years of experience in Medtech and a certification as a lead auditor, Sebastian is instrumental in ensuring that all compliance measures and quality standards are met, upholding and advancing the company's commitment to quality, compliance, and continuous improvement.

Ronja Senn

Head of Marketing and Sales
After completing her Master’s degree in Biomedical Engineering at ETH Zurich, Ronja joined our company in 2021 for her thesis. Starting as an RA/R&D Project Manager, she delved into the pre-market aspects of medical device development. Transitioning into the marketing and sales department, she gained a comprehensive understanding of the entire device lifecycle. Now, as Head of Marketing & Sales, Ronja navigates the commercialization pathway of ZuriMED's products alongside her team.

Catherine Trojer Marcelo

Head of Finance
Catherine, as the Head of Finance at ZuriMED, is an experienced professional with a Master’s degree in Management and extensive experience in the banking industry. Committed to continuous growth, she is currently pursuing further education to become a certified fiduciary. Catherine's leadership ensures financial stability and growth, aligning management practices with organizational objectives.

Mariano Perez Chaher

Supplier Quality Engineer
Since joining in 2022 as an MSc graduate in Industrial Engineering from the University of Groningen, Mariano has become an indispensable member of our team. As Supplier Quality Engineer he ensures product traceability throughout the supply chain, and establishes rigorous procedures to ensure the high quality of our products.

Ricardo Ribeiro

Quality Engineer
Ricardo is a dedicated individual holding an MSc in Health Sciences and Technology from ETH Zürich. As a Quality Engineer at ZuriMED, he maintains high standards within the Quality Management System and Product Development through diligent attention to detail and critical thinking, ensuring compliance with regulations and fostering continuous improvement.

Esteban Doig Cramer

R&D Engineer
Esteban was born and raised in Berlin, before pursuing his studies at ETH Zurich in Mechanical Engineering. Academic projects focusing on engineering for health led to his placement at ZuriMED, starting in fall 2022. He develops medical devices with a strong engineering background, contributes to IP and regulatory proceedings.

Cornelius Schlegel

R&D Engineer
Cornelius, an M.Sc. graduate in Medical Engineering from the University of Stuttgart, brings practical experience from software development at KLS Martin Group and laboratory automation at Fraunhofer IPA. At ZuriMED Technologies AG, he contributes as an R&D engineer, specializing in nonwoven development.

Carlota Sole Escobar

Business Development Manager
With a Master’s degree in Biomedical Engineering from Imperial College London and prior experience at Stryker Sports Medicine, Carlota joined ZuriMED in 2023 as an Engineer. She transitioned into Business Development, driven by her keen interest in scaling the company's reach and forming key partnerships. Carlota now plays a key role in shaping ZuriMED’s vision, collaborating closely with the CEO on fundraising, strategy, and growth initiatives. She also maintains strong ties with surgeons and Key Opinion Leaders, using their clinical insights to guide business development strategies.

Esteban Ongini

R&D Project Manager
Esteban oversees the end-to-end development of spine medical devices, ensuring adherence to quality standards and regulations. Holding degrees in biomedical engineering from Georgia Tech and ETH Zürich, along with experience in product development and research in orthopedic biomechanics, his expertise positions him as an exceptional R&D project manager.

Janick Eglauf

Market Development Manager
Janick holds a Master’s degree in Health Sciences and Technology from ETH Zürich. With previous experience in academia and a biotechnology startup, he has acquired expertise in tissue and biomedical engineering as well as bioprocess optimization. At ZuriMED he works on enabling the market entry for the FiberLocker® Technology and frequently supports R&D projects.

Dominic Spothelfer

R&D Project Manager
Dominic, an R&D Project Manager, holds a bachelor’s in mechanical engineering from McGill University in Canada and a Master of Science in Robotics, Systems, and Control from ETH Zurich. His passion lies in applying his fundamental engineering knowledge to developing innovative medical devices. Currently, Dominic is developing active devices for ZuriMED.

Simon Schnydrig

Senior R&D Project Manager
Simon is responsible for the development of the required instrumentation of a new implant system designed to reduce the risk of a reherniation after a discectomy. As a material scientist and biomechanical engineer from education, previously he worked as a development engineer for dental implants and instruments at Straumann AG.

Blorenta Murseli

Finance Associate
Blorenta, a member of ZuriMED's Finance team, leverages expertise with a Master of Science in International Financial Management to drive financial analysis and business development. With her previous experience in finance within the energy industry, she brings valuable insights to her role. Eager to collaborate and contribute to the team's success, Blorenta embodies dedication and proficiency in her role.

Luana Hess

Business Development Intern
Luana holds a Bachelor's degree in Electrical Engineering with a focus on biosensors and bioelectronics from ETH Zürich. As a Business Development Intern, she contributes by conducting research, supporting investor communications, and collaborating with cross-functional teams to analyze industry trends and explore new business opportunities in the MedTech sector.

Cherilyn Camichel

R&D Engineer
Cherilyn holds a Master’s in Health Sciences and Technology from ETH Zurich. She began her career at ZuriMED as an R&D intern in 2021. After gaining experience in rehabilitation engineering, she completed an internship and her Master’s thesis at the AO Foundation, specializing in biomechanical testing and computer simulations. Now back at ZuriMED as an R&D Engineer, Cherilyn leverages her expertise to lead biocompatibility evaluations and contribute to early R&D projects.

Alicia Wirz

Marketing Associate
Alicia holds a Master of Arts in Communication & Marketing. She brings practical experience from previous roles in marketing departments within different industries. With a strong passion for creativity and her interest in the medical field, she is part of the Sales and Marketing team at ZuriMED to highlight the company’s technology in the marketplace.

Ciara Giles-Doran

R&D Engineer
Ciara holds a MSc. in Bioelectronics from ETH Zürich, completing their master's thesis at Stanford University. At ZuriMED, Ciara contributes to the development of active devices, combining their professional experience as an R&D software engineer at Boston Scientific and academic experience in medical hardware design.

Venerë Kadriu

Finance Intern
Venerë is a Finance Intern at ZuriMED, holding a BBA and an MBA earned in the United States. With a strong foundation in finance and experience in entrepreneurship, she brings both analytical skills and a broad perspective to the team. Currently pursuing an MSc in International Financial Management, Venera is eager to contribute meaningfully while continuing to grow professionally.

Nemanja Kostic

Operations Manager
Nemanja joined ZuriMED in April 2025 as Operations Manager. With a degree in Mechanical Engineering from ETH Zürich, he brings valuable experience from his previous roles as an IT Life Science Consultant and in a family-run construction business. At ZuriMED, he is responsible for coordinating the entire production process, managing the supply chain, and ensuring efficient logistics. He also plays a key role in supporting the company’s efforts to scale up its operations.

Julia Holenstein

R&D Intern
While pursuing her Master´s degree in Mechanical Engineering at ETH, Julia Holenstein is supporting ZuriMED as an R&D Intern. She has an academic background in biomechanical engineering and previous work experience in the medical technology field, and is working with the design and development team on a new medical device.

Stefani Dossi

Clinical Affairs Manager
Stefani holds a Master’s degree in Musculoskeletal Rehabilitation and has completed advanced training in Clinical Trial Management. She brings together clinical experience as a physiotherapist with hands-on expertise in clinical research and trial coordination. At ZuriMED, she contributes to the development of the clinical strategy, helping to support the market approval of our innovative medical devices. As a Clinical Affairs Manager, she coordinates clinical studies with the aim of collecting qualitative clinical evidence.

Our Board of Directors is comprised of world-leading scientists, consultants and clinicians supporting the company in their field of expertise.

Prof. Dr. Jess Snedeker

President of the Board of Directors

Ulrich Looser

Member of the Board of Directors

Tyler Beeson

Member of the Board of Directors

Dr. med. Dominique Tschudi

Vice President of the Board of Directors

Dr. Helen (Ying) Yang

Member of the Board of Directors

Dr. Xiang Li

Member of the Board of Directors

Prof. Dr. Robert Frigg

Member of the Board of Directors

Chan-Yuan Lu

Member of the Board of Directors

The core of ZuriMED is built by its people. Our interdisciplinary and diverse team is backed by a strong board of directors comprised of world-renowned experts. Together, we aim to push the boundaries of current orthopedic and sports medicine solutions through our innovative technologies.

Xiang Li

CEO & Co-Founder
Xiang holds a degree of Dr. sc. ETH Zürich in Orthopaedic Biomechanics, with over 15 years of experience in medical engineering. Along with business development, he has developed a comprehensive knowledge base in finance, legal, quality, and management. With a robust entrepreneurial sense and a firm vision, he leads operations to grow the company, and fosters an incentivising work environment that encourages innovation and motivates the team to create value for the company.

Elias Bachmann

CTO & Co-Founder
After completing his biomedical engineering studies, Elias spent several years as a research fellow at the Laboratory of Orthopaedic Biomechanics, Balgrist University Hospital, and ETH Zürich. His journey led him to co-found ZuriMED Technologies AG, where he is now responsible for the technical direction, strategy and development.

Pol Banzet

Head of Development
With a background in Mechanical Engineering with an orientation in Biomechanics, Pol spent time in academia (Master's Thesis in Harvard's Biodesign Lab and research assistant at ETH's Computational Robotics Laboratory), before joining ZuriMED in 2020. He now supervises the development of multiple medical devices, from early research prototypes to industrialization and early lifecycle management.

Sascha Brun

Head of Active Devices Development
Sascha holds an MSc in Mechanical Engineering, specializing in Robotics and Mechatronics, from ETH Zurich. He leads the development of powered devices at ZuriMED. After a traineeship at the Helbling Robotics Team and a research assistant position at the biomechanics lab, Sascha joined ZuriMED from the early days on.

Andrea Möhl

Head of Clinical Affairs
Andrea, Head of Clinical Affairs, holds an MSc in Health Science and Technology from ETH Zurich. She leads pre-clinical and clinical studies, playing a pivotal role in clinical evaluation processes. After a traineeship at DePuy Synthes and a research internship in the rehabilitation engineering field, Andrea joined ZuriMED for her master’s thesis and supported the Surgical-Fiberlock technology project from its early stages.

Sebastian Arevalo

Head of Quality
Sebastian leads ZuriMED's quality and regulatory compliance department. Backed by more than six years of experience in Medtech and a certification as a lead auditor, Sebastian is instrumental in ensuring that all compliance measures and quality standards are met, upholding and advancing the company's commitment to quality, compliance, and continuous improvement.

Ronja Senn

Head of Marketing and Sales
After completing her Master's Degree in Biomedical Engineering at ETH Zurich, Ronja joined our company in 2021 for her thesis. Starting as an RA/R&D Project Manager, she delved into the pre-market aspects of medical device development. Transitioning into the marketing and sales department, she gained a comprehensive understanding of the entire device lifecycle. Now, as Head of Marketing & Sales, Ronja navigates the commercialization pathway of ZuriMED's products alongside her team.

Catherine Trojer Marcelo

Head of Finance
Catherine, as the Head of Finance at ZuriMED, is an experienced professional with a Master's degree in Management and extensive experience in the banking industry. Committed to continuous growth, she is currently pursuing further education to become a certified fiduciary. Catherine's leadership ensures financial stability and growth, aligning management practices with organizational objectives.

Mariano Perez Chaher

Supplier Quality Engineer
Since joining in 2022 as an MSc graduate in Industrial Engineering from the University of Groningen, Mariano has become an indispensable member of our team. As Supplier Quality Engineer he ensures product traceability throughout the supply chain, and establishes rigorous procedures to ensure the high quality of our products.

Ricardo Ribeiro

Quality Engineer
Ricardo is a dedicated individual holding an MSc in Health Sciences and Technology from ETH Zürich. As a Quality Engineer at ZuriMED, he maintains high standards within the Quality Management System and Product Development through diligent attention to detail and critical thinking, ensuring compliance with regulations and fostering continuous improvement.

Esteban Doig Cramer

R&D Engineer
Esteban was born and raised in Berlin, before pursuing his studies at ETH Zurich in Mechanical Engineering. Academic projects focusing on engineering for health led to his placement at ZuriMED, starting in fall 2022. He develops medical devices with a strong engineering background, contributes to IP and regulatory proceedings.

Cornelius Schlegel

R&D Engineer
Cornelius, an M.Sc. graduate in Medical Engineering from the University of Stuttgart, brings practical experience from software development at KLS Martin Group and laboratory automation at Fraunhofer IPA. At ZuriMED Technologies AG, he contributes as an R&D engineer, specializing in nonwoven development.

Carlota Sole Escobar

Business Development Manager
With a Master’s degree in Biomedical Engineering from Imperial College London and prior experience at Stryker Sports Medicine, Carlota joined ZuriMED in 2023 as an Engineer. She transitioned into Business Development, driven by her keen interest in scaling the company's reach and forming key partnerships. Carlota now plays a key role in shaping ZuriMED’s vision, collaborating closely with the CEO on fundraising, strategy, and growth initiatives. She also maintains strong ties with surgeons and Key Opinion Leaders, using their clinical insights to guide business development strategies.

Esteban Ongini

R&D Project Manager
Esteban oversees the end-to-end development of spine medical devices, ensuring adherence to quality standards and regulations. Holding degrees in biomedical engineering from Georgia Tech and ETH Zürich, along with experience in product development and research in orthopedic biomechanics, his expertise positions him as an exceptional R&D project manager.

Janick Eglauf

Market Development Manager
Janick holds a Master‘s Degree in Health Sciences and Technology from ETH Zürich. With previous experience in academia and a biotechnology startup, he has acquired expertise in tissue and biomedical engineering as well as bioprocess optimization. At ZuriMED he works on enabling the market entry for the FiberLocker® Technology and frequently supports R&D projects.

Dominic Spothelfer

R&D Project Manager
Dominic, an R&D Project Manager, holds a bachelor’s in mechanical engineering from McGill University in Canada and a Master of Science in Robotics, Systems, and Control from ETH Zurich. His passion lies in applying his fundamental engineering knowledge to developing innovative medical devices. Currently, Dominic is developing active devices for ZuriMED.

Simon Schnydrig

Senior R&D Project Manager
Simon is responsible for the development of the required instrumentation of a new implant system designed to reduce the risk of a reherniation after a discectomy. As a material scientist and biomechanical engineer from education, previously he worked as a development engineer for dental implants and instruments at Straumann AG.

Blorenta Murseli

Finance Associate
Blorenta, a member of ZuriMED's Finance team, leverages expertise as a Master of Science in International Financial Management to drive financial analysis and business development. With her previous experience in finance within the energy industry, she brings valuable insights to her role. Eager to collaborate and contribute to the team's success, Blorenta embodies dedication and proficiency in her role.

Luana Hess

Business Development Intern
Luana holds a Bachelor's degree in Electrical Engineering with a focus on biosensors and bioelectronics from ETH Zürich. As a Business Development Intern, she contributes by conducting research, supporting investor communications, and collaborating with cross-functional teams to analyze industry trends and explore new business opportunities in the MedTech sector.

Cherilyn Camichel

R&D Engineer
Cherilyn holds a Master’s in Health Sciences and Technology from ETH Zurich. She began her career at ZuriMED as an R&D intern in 2021. After gaining experience in rehabilitation engineering, she completed an internship and her Master’s thesis at the AO Foundation, specializing in biomechanical testing and computer simulations. Now back at ZuriMED as an R&D Engineer, Cherilyn leverages her expertise to lead biocompatibility evaluations and contribute to early R&D projects.

Alicia Wirz

Marketing Associate
Alicia holds a Master of Arts in Communication & Marketing. She brings practical experience from previous roles in marketing departments within different industries. With a strong passion for creativity and her interest in the medical field, she is part of the Sales and Marketing team at ZuriMED to highlight the company’s technology in the marketplace.

Maria Doikova

R&D Intern
Maria is pursuing a Master’s Degree in Health Science and Technology at ETH Zürich. She possesses a strong academic and practical background in biology, and is currently specializing in medical technology as part of her studies. She has joined ZuriMED as an R&D Intern, where she is working with the design and development team on a new medical device, and occasionally providing support with clinical affairs.

Giuditta Thoma

Quality & Compliance Intern
Giuditta holds a MSc in Biomedical Engineering from the University of Bern. Thanks to her background and previous experience as researcher in the biotech industry, she now provides valuable insights to the Quality Department at ZuriMED. She is eager to support the team in the mission to improve the quality of life of patients by delivering high-quality products and ensuring their compliance with regulatory and normative requirements.

Ciara Giles-Doran

R&D Engineer
Ciara holds a MSc. in Bioelectronics from ETH Zürich, completing their master's thesis at Stanford University. At ZuriMED, Ciara contributes to the development of active devices, combining their professional experience as an R&D software engineer at Boston Scientific and academic experience in medical hardware design.

Venerë Kadriu

Finance Intern
Venera is a Finance Intern at ZuriMED, holding a BBA and an MBA earned in the United States. With a strong foundation in finance and experience in entrepreneurship, she brings both analytical skills and a broad perspective to the team. Currently pursuing an MSc in International Financial Management, Venera is eager to contribute meaningfully while continuing to grow professionally.

Nemanja Kostic

Operations Manager
Nemanja joined ZuriMED in April 2025 as Operations Manager. With a degree in Mechanical Engineering from ETH Zürich, he brings valuable experience from his previous roles as an IT Life Science Consultant and in a family-run construction business. At ZuriMED, he is responsible for coordinating the entire production process, managing the supply chain, and ensuring efficient logistics. He also plays a key role in supporting the company’s efforts to scale up its operations.

Julia Holenstein

R&D Intern
While pursuing her Master´s Degree in Mechanical Engineering at ETH, Julia Holenstein is supporting ZuriMED as an R&D Intern. She has an academic background in biomechanical engineering and previous work experience in the medical technology field, and is working with the design and development team on a new medical device.

Stefani Dossi

Clinical Affairs Manager
Stefani holds a Master’s degree in Musculoskeletal Rehabilitation and has completed advanced training in Clinical Trial Management. She brings together clinical experience as a physiotherapist with hands-on expertise in clinical research and trial coordination. At ZuriMED, she contributes to the development of the clinical strategy, helping to support the market approval of our innovative medical devices. As a Clinical Affairs Manager, she coordinates clinical studies with the aim of collecting qualitative clinical evidence.

Our Board of Directors is comprised of world-leading scientists, consultants and clinicians supporting the company in their field of expertise.

Prof. Dr. Jess Snedeker

President of the Board of Directors

Ulrich Looser

Member of the Board of Directors

Tyler Beeson

Member of the Board of Directors

Dr. med. Dominique Tschudi

Vice-President of the Board of Directors

Dr. Helen (Ying) Yang

Member of the Board of Directors

Dr. Xiang Li

Member of the Board of Directors

Prof. Dr. Robert Frigg

Member of the Board of Directors

Chan-Yuan Lu

Member of the Board of Directors

Careers

We are constantly seeking innovative talents. If you believe you are the perfect fit for our team, please send a spontaneous application to: application@zurimed.com

We are looking forward to meeting you!

Careers

We are constantly seeking innovative talents. If you believe you are the perfect fit for our team, please send a spontaneous application to: application@zurimed.com

We are looking forward to meeting you!

Get to Know Us

ZuriMED originated in Zurich, Switzerland, and is part of the Swiss health cluster. Surrounded by world-leading universities and orthopedic healthcare institutes, we have unique access to high-quality labs, clinical knowledge, and exceptionally skilled talents.

The startup spun off from the University of Zurich and ETH Zurich in 2015 and is supported by Balgrist Beteiligungs AG. With this, we benefit from a close collaboration with research groups and clinicians, accelerating the transition from bench to bedside.

Our Values

Innovation

We embrace creativity and entrepreneurial thinking, developing groundbreaking technologies to pioneer advancements and reshape the future of healthcare.

Ambition

Our relentless pursuit of excellence and our vision of improving patients’ lives drive us to set new benchmarks in the industry.

Reliability

We are committed to creating a working environment where employees can trust each other while delivering high-quality products and services that healthcare professionals as well as patients can rely on.

Our Mission

ZuriMED strives to develop innovative technologies that overcome current limitations in soft tissue repair by leveraging our pragmatic, agile, and motivated team in close collaboration with healthcare professionals.

Our Vision

We envision a future where our products have redefined modern surgical practices to maximize the quality of physicians’ treatment options and patients’ lives.

Sustainability

At ZuriMED, we are driven by the mission of sustainable innovation and guided by our vision for a better future — not only revolutionizing soft tissue repair in sports medicine but also fostering healthy competition in the MedTech industry while focusing on local environmental impact.

Our Sustainability Goal

Creating a fair workspace where diversity and inclusion are embraced, while focusing on local initiatives and partnerships. We not only take the well-being of our patients and employees seriously but also uphold our responsibility to local communities.

Get to Know Us

ZuriMED originated in Zurich, Switzerland, and is part of the Swiss health cluster. Surrounded by world-leading universities and orthopedic healthcare institutes, we have unique access to high-quality labs, clinical knowledge, and exceptionally skilled talents.

The startup spun off from the University of Zurich and ETH Zurich in 2015 and is supported by Balgrist Beteiligungs AG. With this, we benefit from close collaborations with research groups and clinicians, accelerating the transition from bench to bedside.

Our Impact

Our Values

Innovation

We embrace creativity and entrepreneurial thinking, developing groundbreaking technologies to pioneer advancements and reshape the future of healthcare.

Ambition

Our relentless pursuit of excellence and our vision of improving patients’ lives drive us to set new benchmarks in the industry.

Reliability

We are committed to creating a working environment where employees can trust each other while delivering high-quality products and services that healthcare professionals as well as patients can rely on.

Our Mission

ZuriMED strives to develop innovative technologies that overcome current limitations in soft tissue repair by leveraging our pragmatic, agile, and motivated team in close collaboration with healthcare professionals.

Our Vision

We envision a future where our products have redefined modern surgical practices to maximize the quality of physicians’ treatment options and patients’ lives.

Sustainability

At ZuriMED, we are driven by the mission of sustainable innovation and guided by our vision for a better future — not only revolutionizing soft tissue repair in sports medicine but also fostering healthy competition in the MedTech industry while focusing on local environmental impact.

Our Sustainability Goal

Creating a fair workspace where diversity and inclusion are embraced, while focusing on local initiatives and partnerships. We not only take the well-being of our patients and employees seriously but also uphold our responsibility to local communities.

History

Scroll through our company’s history and explore the key milestones that have shaped ZuriMED’s journey.

2025 | Market Launch

The 12th of February marks the day of the market entry of the FiberLocker System in the U.S. Since then, the reinforcement system is commercially available and can be used for rotator cuff augmentation in the clinical setting.

Furthermore, a first-in-human clinical study in Switzerland and a multicenter clinical study in the U.S. have been initiated.

2024 | FiberLocker System receives FDA Clearance

In December 2024, ZuriMED Technologies AG celebrated a significant achievement: the FDA clearance of our 510(k) submission for the FiberLocker® System. This represents the first clinical indication of the pioneering Surgical-Fiberlock® technology. We anticipate a limited U.S. market release of the SpeedPatch® PET and FiberLocker® Instrument in early 2025, allowing patients to soon benefit from this new technology.

2023 | ZuriMED closes Series-A financing round & receives Innosuisse Swiss Accelerator Grant

The financing round was led by Chindex Medical Limited (Hong Kong), followed by Yellowstone Holding AG (Geneva) and a group of private investors that includes leading orthopaedic surgeons from Switzerland, Germany, France, and the United States. An additional non-diluting funding from Innosuisse will greatly expedite the development and regulatory registration process of a second clinical indication.

2022 | ZuriMED obtains Innosuisse Scale-up Award & Innosuisse Project Grant

Thanks to this award, ZuriMED can access the second phase of the Scale-up Coaching program to further accelerate the growth in Switzerland and the expansion into new global markets. The Project Grant supports the co-development with research partner University Hospital Balgrist on ZuriMED’s breakthrough technology for soft tissue repair.

2021 | ISO 13485 certificate obtained

ZuriMED achieves ISO 13485 certification through BSI

2020 | ZuriMED closes a license deal with an international medical device company

One of ZuriMED’s endocortical fixation technologies for soft tissue repair has been licensed to an international medical device company. A strategic partnership has been established to work together to bring this technology to clinical applications.

2019 | ZuriMED obtains the Innosuisse Certificate

The company has now obtained the Innosuisse certificate in recognition for the potential of its technology and solutions. The role of Innosuisse – the Swiss Innovation Agency – is to promote science-based innovation in the interests of industry and society in Switzerland.

2018 | Capital increase – loan conversion executed

Loan conversion of the seed round investment into equity.

2017 | Start of Innosuisse funded First-in-man study

Clinical trial on ZuriMED’s first product, the BTB-Converter™ was approved by Swissethics and sponsored by Innosuisse (formerly Commission for Technology and Innovation in Switzerland [CTI]).

2016 | Seed round investment received

Investment in terms of convertible loan. ZuriMED moves into the newly opened Balgrist Campus.

2015 | Incorporation of ZuriMED Technologies AG

Winner of Venture Kick Final, Switzerland’s largest start-up acceleration program. Presenting 2nd best business plan by >>venture>>, the leading competition for entrepreneurs in Switzerland, a joint initiative of ETH Zurich, McKinsey & Company, Knecht Holding, Innosuisse and EPFL.

Past Projects

BTB-Converter™

Knee ligament reconstruction

Eight years of advanced biomaterial research and translational development at the University and ETH Zürich, in collaboration with leading Swiss surgeons, has led to ZuriMED’s Bone-Tendon-Bone (BTB)-Converter™ for knee ligament reconstruction.

This technology was developed by ZuriMED in the past and has now been out-licensed.

 

VariLoop™

Superior ligament fixation

The single-strand VariLoop™ enables superior ligament fixation. It is simple, easy to use, self-flipping, and truly knotless. The technology’s high reliability and strength have been proven under all testing conditions. This implant can be used in various configurations for many indications where tension or compression is critical for healing.

This technology was developed by ZuriMED in the past and has now been out-licensed.

 

History

Scroll through our company’s history and explore the key milestones that have shaped ZuriMED’s journey.

2024 | FiberLocker System receives FDA Clearance

In December 2024, ZuriMED Technologies AG celebrated a significant achievement: the FDA clearance of our 510(k) submission for the FiberLocker® System. This represents the first clinical indication of the pioneering Surgical-Fiberlock® technology. We anticipate a limited U.S. market release of the SpeedPatch® PET and FiberLocker® Instrument SN in early 2025, allowing patients to soon benefit from this new technology.

2023 | ZuriMED closes Series-A financing round & receives Innosuisse Swiss Accelerator Grant

The financing round was led by Chindex Medical Limited (Hong Kong), followed by Yellowstone Holding AG (Geneva) and a group of private investors that includes leading orthopaedic surgeons from Switzerland, Germany, France, and the United States. An additional non-diluting funding from Innosuisse will greatly expedite the development and regulatory registration process of a second clinical indication.

2022 | ZuriMED obtains Innosuisse Scale-up Award & Innosuisse Project Grant

Thanks to this award, ZuriMED can access the second phase of the Scale-up Coaching program to further accelerate the growth in Switzerland and the expansion into new global markets. The Project Grant supports the co-development with research partner University Hospital Balgrist on ZuriMED’s breakthrough technology for soft tissue repair.

2021 | ISO 13485 certificate obtained

ZuriMED achieves ISO 13485 certification through BSI

2020 | ZuriMED closes a license deal with an international medical device company

One of ZuriMED’s endocortical fixation technologies for soft tissue repair has been licensed to an international medical device company. A strategic partnership has been established to work together to bring this technology to clinical applications.

2019 | ZuriMED obtains the Innosuisse Certificate

The company has now obtained the Innosuisse certificate in recognition for the potential of its technology and solutions. The role of Innosuisse – the Swiss Innovation Agency – is to promote science-based innovation in the interests of industry and society in Switzerland.

2018 | Capital increase – loan conversion executed

Loan conversion of the seed round investment into equity.

2017 | Start of Innosuisse funded First-in-man study

Clinical trial on ZuriMED’s first product, the BTB-Converter™ was approved by Swissethics and sponsored by Innosuisse (formerly Commission for Technology and Innovation in Switzerland [CTI]).

2016 | Seed round investment received

Investment in terms of convertible loan. ZuriMED moves into the newly opened Balgrist Campus.

2015 | Incorporation of ZuriMED Technologies AG

Winner of Venture Kick Final, Switzerland’s largest start-up acceleration program. Presenting 2nd best business plan by >>venture>>, the leading competition for entrepreneurs in Switzerland, a joint initiative of ETH Zurich, McKinsey & Company, Knecht Holding, Innosuisse and EPFL.

Past Projects

BTB-Converter™

Knee ligament reconstruction

Eight years of advanced biomaterial research and translational development at the University and ETH Zürich, in collaboration with leading Swiss surgeons, has led to ZuriMED’s Bone-Tendon-Bone (BTB)-Converter™ for knee ligament reconstruction.

This technology was developed by ZuriMED in the past and has now been out-licensed.

 

VariLoop™

Superior ligament fixation

The single-strand VariLoop™ enables superior ligament fixation. It is simple, easy to use, self-flipping, and truly knotless. The technology’s high reliability and strength have been proven under all testing conditions. This implant can be used in various configurations for many indications where tension or compression is critical for healing.

This technology was developed by ZuriMED in the past and has now been out-licensed.